Cargando…

Ceftriaxone Treatment for Neuronal Deficits: A Histological and MEMRI Study in a Rat Model of Dementia with Lewy Bodies

Dementia with Lewy bodies (DLB) is characterized by neuronal deficits and α-synuclein inclusions in the brain. Ceftriaxone (CEF), a β-lactam antibiotic, has been suggested as a therapeutic agent in several neurodegenerative disorders for its abilities to counteract glutamate-mediated toxicity and to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ho, Ying-Jui, Weng, Jun-Cheng, Lin, Chih-Li, Shen, Mei-Shiuan, Li, Hsin-Hua, Liao, Wen-Chieh, Tsai, Nu-Man, Hung, Ching-Sui, Lai, Te-Jen, Lee, I-Yen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092970/ https://www.ncbi.nlm.nih.gov/pubmed/30154934 http://dx.doi.org/10.1155/2018/4618716

Ejemplares similares

Use of Ceftriaxone in Treating Cognitive and Neuronal Deficits Associated With Dementia With Lewy Bodies
por: Ho, Ying-Jui, et al.
Publicado: (2019)

A new opportunity for MEMRI
por: Cloyd, Ryan, et al.
Publicado: (2017)

Depression in dementia with Lewy bodies: A comparison with Alzheimer's disease
por: Chiu, Pai-Yi, et al.
Publicado: (2017)

Neuropsychiatric Symptoms in Parkinson’s Disease Dementia Are More Similar to Alzheimer’s Disease than Dementia with Lewy Bodies: A Case-Control Study
por: Chiu, Pai-Yi, et al.
Publicado: (2016)

In Vivo Visualization of Active Polysynaptic Circuits With Longitudinal Manganese-Enhanced MRI (MEMRI)
por: Almeida-Corrêa, Suellen, et al.
Publicado: (2018)

Viability imaging of stem cell using a MRI reporter gene and MEMRI
por: Chung, Jaehoon, et al.
Publicado: (2009)

Hippocampal changes in inflammasomes, apoptosis, and MEMRI after radiation-induced brain injury in juvenile rats
por: Yang, Jun, et al.
Publicado: (2020)

Behavioural and Cognitive Changes in Lewy Body Dementias
por: Kung, Woon-Man, et al.
Publicado: (2018)

Increasing Ceftriaxone Resistance in Salmonellae, Taiwan
por: Su, Lin-Hui, et al.
Publicado: (2011)

Lewy body disease and dementia with Lewy bodies
por: KOSAKA, Kenji
Publicado: (2014)

In Vivo Tracking of Transplanted Mononuclear Cells Using Manganese-Enhanced Magnetic Resonance Imaging (MEMRI)
por: Odaka, Kenichi, et al.
Publicado: (2011)

Dementia with Lewy bodies
por: McKeith, Ian
Publicado: (2004)

Longitudinal MEMRI analysis of brain phenotypes in a mouse model of Niemann-Pick Type C disease
por: Rallapalli, Harikrishna, et al.
Publicado: (2020)

Spread Deficits in Initiation, Speed and Accuracy of Horizontal and Vertical Automatic Saccades in Dementia with Lewy Bodies
por: Kapoula, Zoi, et al.
Publicado: (2010)

Neuroimaging characteristics of dementia with Lewy bodies
por: Mak, Elijah, et al.
Publicado: (2014)

Neuroimaging in Lewy body dementia
por: Yousaf, Tayyabah, et al.
Publicado: (2018)

Microbleeds in dementia with Lewy bodies
por: Donaghy, Paul C., et al.
Publicado: (2020)

Advances in dementia with Lewy bodies
por: Armstrong, Melissa J.
Publicado: (2021)

Neuroimaging in Dementia With Lewy Bodies
por: Saha, Abhishikta, et al.
Publicado: (2021)

Combining systemic and stereotactic MEMRI to detect the correlation between gliosis and neuronal connective pathway at the chronic stage after stroke
por: Hao, Xiao-zhu, et al.
Publicado: (2016)

Delusions in Patients with Dementia with Lewy Bodies and the Associated Factors
por: Tzeng, Ray-Chang, et al.
Publicado: (2018)

In vivo MEMRI characterization of brain metastases using a 3D Look-Locker T1-mapping sequence
por: Castets, Charles R., et al.
Publicado: (2016)

Isotropic 25-Micron 3D Neuroimaging Using ex vivo Microstructural Manganese-Enhanced MRI (MEMRI)
por: Sato, Chika, et al.
Publicado: (2018)

Manganese-enhanced MRI (MEMRI) in breast and prostate cancers: Preliminary results exploring the potential role of calcium receptors
por: Baio, Gabriella, et al.
Publicado: (2020)

The gesture imitation test in dementia with Lewy bodies and Alzheimer's disease dementia
por: Li, Xudong, et al.
Publicado: (2022)

Does feedback of medication execution using MEMS caps aid adherence to HAART?: the MEMRI study (MEMS as Realistic Intervention)
por: Davies, S, et al.
Publicado: (2010)

Comprehensive treatment of dementia with Lewy bodies
por: Boot, Brendon P
Publicado: (2015)

Neurophysiological biomarkers for Lewy body dementias
por: Cromarty, Ruth A., et al.
Publicado: (2016)

Exome sequencing in dementia with Lewy bodies
por: Keogh, M J, et al.
Publicado: (2016)

Clinical prevalence of Lewy body dementia
por: Kane, Joseph P. M., et al.
Publicado: (2018)

Dementia with Lewy bodies: an update and outlook
por: Outeiro, Tiago Fleming, et al.
Publicado: (2019)

Young-Onset Dementia with Lewy Bodies
por: Aiba, Yosuke, et al.
Publicado: (2018)

Pharmacological Management of Dementia with Lewy Bodies
por: Hershey, Linda A., et al.
Publicado: (2019)

Spatial Perseveration in Dementia with Lewy Bodies
por: Assal, Frédéric, et al.
Publicado: (2007)

Clinical diagnosis of Lewy body dementia
por: Surendranathan, Ajenthan, et al.
Publicado: (2020)

Gut microbiota in dementia with Lewy bodies
por: Nishiwaki, Hiroshi, et al.
Publicado: (2022)

Onset matters in dementia with Lewy bodies
por: Müller, Sebastian Johannes, et al.
Publicado: (2023)

Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?
por: Jellinger, Kurt A., et al.
Publicado: (2018)

Cortical thinning in dementia with Lewy bodies and Parkinson disease dementia
por: Colloby, Sean J, et al.
Publicado: (2019)

Antiamoebic Properties of Ceftriaxone and Zinc-Oxide–Cyclodextrin-Conjugated Ceftriaxone
por: Makhlouf, Zinb, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1l3ltf6qgd6ilqgdmmp0cmtrhm